Replimune (REPL) Other Accumulated Expenses (2018 - 2026)
Replimune (REPL) reported Other Accumulated Expenses of $514,000 for fiscal Q4 2021 (quarter ended Mar 31, 2021), up 69.6% from $303,000 a year earlier but down 1.0% from the prior quarter.
Powered by 
Analysis
Replimune (REPL) Other Accumulated Expenses (2018 - 2026) Analysis & Trends
Dating back to fiscal Q4 2018, Replimune's Other Accumulated Expenses record includes 13 quarters.
- Other Accumulated Expenses has increased for three consecutive fiscal years, with a three-year compound annual growth rate of 49.8% (FY2018 to FY2021).
- By fiscal year, Other Accumulated Expenses came in at $303,000 in FY2020 (+11.0%), $273,000 in FY2019 (+78.4%) and $153,000 in FY2018.
- Five-year quarterly Other Accumulated Expenses spans a low of $129,000 in fiscal Q1 2019 and a high of $974,000 in fiscal Q2 2021.
- Year over year, Other Accumulated Expenses has now increased in each of the last nine quarters, with growth averaging 106.4% over the last eight quarters.
- Across the past five years, year-over-year growth in Other Accumulated Expenses ran from 2.3% in fiscal Q1 2020 to 335.6% in fiscal Q1 2021.
- Per Business Quant data, the three fiscal quarters before Q4 2021 came in at $519,000 (Q3 2021), $974,000 (Q2 2021) and $575,000 (Q1 2021).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Replimune | 2.21 Bn | 1.17 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 1.11 Mn |
| Jun 30, 2026 | 1.14 Mn |
| Mar 31, 2026 | 1.16 Mn |
| Dec 31, 2025 | 1.21 Mn |
| Sep 30, 2025 | 1.21 Mn |
| Jun 30, 2025 | 1.22 Mn |
| Mar 31, 2025 | 1.18 Mn |
| Dec 31, 2024 | 1.16 Mn |
| Sep 30, 2024 | 1.20 Mn |
| Jun 30, 2024 | 1.16 Mn |
| Mar 31, 2024 | 1.16 Mn |
| Dec 31, 2023 | 1.16 Mn |
| Sep 30, 2023 | 1.14 Mn |
| Jun 30, 2023 | 1.14 Mn |
| Mar 31, 2023 | 1.12 Mn |
| Dec 31, 2022 | 1.04 Mn |
| Sep 30, 2022 | 1.00 Mn |
| Jun 30, 2022 | 1.04 Mn |
| Mar 31, 2022 | 1.07 Mn |
| Dec 31, 2021 | 1.07 Mn |
API Access
Replimune Other Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=REPL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-accumulated-expenses", "ticker": "REPL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=REPL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();